Traditional Chinese medicine in HIV cure

15 Feb 2017

1

A special issue on progress toward a cure for HIV includes a description of a previously unreported study started in the early 2000s that describes AIDS patients, currently aged between 51 and 67, being in good health.

These nine individuals were treated with a unique formula of traditional Chinese herbal medicine (TCM) from 2001-2006 or longer, with or without occasional antiviral therapy added later.

The fact that the patients currently have low or undetectable HIV in their systems is unexpected and intriguing, and suggests a potential promise of TCM as a functional cure for HIV / AIDS, as discussed in a "Letter to the Editor" in the special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

The Letter to the Editor is available open access on the AIDS Research and Human Retroviruses website.

In Long-Term Survival of AIDS Patients Treated with Only Traditional Chinese Medicine, Yifei Wang, Fujun Jin, Qiaoli Wang, and Zucai Suo, Jinan University (Guangdong, China) and The Ohio State University (Columbus), report that most of the individuals in this small study have undetectable viral loads, with one patient having a low viral load. Their CD4+ counts and CD4+/CD8+ ratios are all excellent.

In an accompanying Editorial titled Can a Traditional Chinese Medicine Contribute to a Cure for HIV? Thomas Hope, PhD, editor-in-chief of AIDS Research and Human Retroviruses and Professor of Cell and Molecular Biology at Northwestern University, Feinberg School of Medicine (Chicago, IL), while pointing out the limitations in interpreting the outcome of this small, non-placebo-controlled study, comments on the importance of putting "these observations into the hands of the HIV research community." He writes, "I believe there should be some effort to further explore this phenomenon."

Both the Letter to the Editor and Editorial are part of a new Special Issue on HIV Cure Research published in AIDS Research and Human Retroviruses.

Latest articles

Anthropic’s revenue run-rate doubles in India in four months as Claude adoption surges

Anthropic’s revenue run-rate doubles in India in four months as Claude adoption surges

Alibaba launches Qwen3.5 as competition heats up in the 'agentic AI' race

Alibaba launches Qwen3.5 as competition heats up in the 'agentic AI' race

Big Tech loses billions as AI spending concerns weigh on valuations

Big Tech loses billions as AI spending concerns weigh on valuations

The analog antidote: why Americans are trading algorithms for physical media

The analog antidote: why Americans are trading algorithms for physical media

UK weighs faster defence spending hike toward 3% as security pressures mount

UK weighs faster defence spending hike toward 3% as security pressures mount

China opens market to 53 African nations in zero-tariff pivot

China opens market to 53 African nations in zero-tariff pivot

Modi’s rooftop solar push slows as lenders and states drag feet

Modi’s rooftop solar push slows as lenders and states drag feet

India hosts global AI summit as tech leaders gather in Delhi amid investment push

India hosts global AI summit as tech leaders gather in Delhi amid investment push

OpenClaw founder Peter Steinberger joins OpenAI as personal-agent project moves to foundation

OpenClaw founder Peter Steinberger joins OpenAI as personal-agent project moves to foundation